http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005094602-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dfc70b99011dadbade572beb0b30c02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec2cf2772a722c89d7cdeaf3f7f441cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9f2dd90b77b49ea2eb2eeea0272735f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23J1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23J1-14
filingDate 2005-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5b78030ecac1b0b660a5d65431734ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44a20ef009fc8625778c345a66ef9d0a
publicationDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005094602-A2
titleOfInvention Purified extract of an alpha-amylase inhibitor from phytoemagglutinin-essentially free beans, process for its extraction and compositions containing it
abstract The invention relates to the use of beans essentially free from phytohemagglutinin for extracting the alpha-amylase inhibitor (hereinafter also “phaseolamin”), the extract enriched in phaseolamin, the highly purified extract, and also the dietetic and pharmaceutical compositions that contain, it; the invention also relates to a process for preparing the above extract and for the immobilisation of phaseolamin on an inert solid support.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008107182-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007071334-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2934468-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008107182-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1967200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007071333-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007071334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007071333-A2
priorityDate 2004-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1295535-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004002239-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4063834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID358
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID358
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453962614
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135885241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3885
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419510309
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24763
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419590759
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420298

Total number of triples: 50.